Sagers Posts Again on HuffingtonPost, This Time on the “Reverse Payments” Drug Case

C|M|Law’s James A. Thomas Distinguished Professor of Law Chris Sagers had a new post  on the HuffingtonPost last week concerning last week’s Supreme Court decision in Federal Trade Commission v. Actavis, Inc.  In the case, the Court held that so-called “reverse payment” or “pay for delay” agreements between branded drug manufacturers and would-be generic competitors are not only subject to antitrust law, but are likely illegal in any case in which the reverse payment is “large.”  Sagers offers thoughts about why the case matters not just for the narrow context of the drug sector, but for antitrust law and competition generally.

You may read Sagers’ post here:

This entry was posted in Faculty in the Media. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s